January Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
January Capital Advisors's AMGN Position: Q2 2026 in Review
January Capital Advisors reduced its Amgen (AMGN) stake by 0.11% in Q2 2026, selling an estimated $2.4K and leaving 6,400 shares worth $2.32M. The position accounts for 1.94% of the portfolio, ranked #15.
January Capital Advisors first reported a position in AMGN in Q4 2021 and has held it in 5 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- January Capital Advisors held 6,400 shares of Amgen worth $2.32M as of Q2 2026.
- January Capital Advisors sold 7 Amgen shares in Q2 2026, an estimated $2.4K.
- Amgen made up 1.94% of January Capital Advisors's portfolio in Q2 2026, its #15 holding.
- January Capital Advisors first reported a position in Amgen in Q4 2021 and has held it in 5 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on January Capital Advisors's 13F filing for Q2 2026, filed 25 Aug 2026.